Matthew Smith is listed as a director on 3 SEC Form D filings by 3 issuers between Aug 2025 and Sep 2026: ROC Holdings SPV II, LP (Washington, DC — biotechnology — 2025; $3.65M reported sold to 16 investors), ROC Holdings SPV IV, LP (Washington, DC — pooled investment fund — 2026) and ROC Holdings SPV III, LP (Washington, DC — biotechnology — 2026).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director. Across those companies the filings report $3.65M sold in total.
Listed alongside James Dahlman (3 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Matthew. Each name links to their own page.
All 3 issuers belong to the sponsor group Roc (7 issuers, $15.5M reported sold, 2019–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Roc has 7 companies on file and $15.5M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Matthew Smith and found 7 differences, 1 worth asking the sponsor about: Form D filed 463 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.